Chamlin will spearhead the development and implementation of commercial strategies for Aspargo's groundbreaking oral spray ...

The FDA has granted fast-track approval for a groundbreaking gene therapy indicated for a rare genetic disorder called aromatic L-amino acid decarboxylase (AADC) deficiency.

Real-world data show reduction in use of urate-lowering therapy among people with type 2 diabetes using SGLT2 inhibitors.

The combination of sacubitril and valsartan reduces the cardiotoxicity related to anthracycline chemotherapy drugs, according ...

More than half the women in the treat-to-target group conceived within 3 months vs a median of 6.5 months for those in the ...

Dupilumab (Dupixent), a fully human monoclonal antibody that targets the interleukin (IL)-4 and IL-13 pathways, is currently ...

Muvalaplin shows promise in lowering lipoprotein(a) levels, which are genetically determined and confer cardiovascular risk ...

Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced working memory, as seen in mental health conditions ...

Valuable data can successfully be collected with the noninvasive wearable, which is worn on the sternum, report investigators ...

Most patients with rheumatoid arthritis or spondyloarthritis had significant antibody responses to COVID vaccine boosters, whether or not their immunomodulatory medications were held.

The US Food and Drug Administration (FDA) has accepted a resubmission of the supplemental Biologics License Application for ...

As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.